We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.08B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+85.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.08B
AUM Growth
-$124M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
264
New
Increased
Reduced
Closed

Top Buys

1
+$24.8M
2
+$16.6M
3
+$15.8M
4
LLY icon
Eli Lilly
LLY
+$15.2M
5
GPC icon
Genuine Parts
GPC
+$13M

Top Sells

1
+$30.9M
2
+$24.7M
3
+$13.6M
4
SUNC
SunocoCorp LLC
SUNC
+$11.6M
5
GXO icon
GXO Logistics
GXO
+$10.6M

Sector Composition

1 Healthcare 42.57%
2 Consumer Discretionary 13.87%
3 Financials 12.06%
4 Industrials 6.62%
5 Materials 6.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ECXWW
201
ECARX Holdings Warrants
ECXWW
$1.38M
$6.5K ﹤0.01%
125,000
MSAIW icon
202
MultiSensor AI Holdings Warrant
MSAIW
$989K
$5.87K ﹤0.01%
150,000
ORIQW
203
Origin Investment Corp I Warrant
ORIQW
$2.02K ﹤0.01%
15,000
APLMW icon
204
Apollomics Inc Warrant
APLMW
$1.17M
$1.98K ﹤0.01%
130,000
ADMA icon
205
ADMA Biologics
ADMA
$1.92B
– –
0
AKA icon
206
a.k.a. Brands
AKA
$99M
– –
-36,417
ANIX icon
207
Anixa Biosciences
ANIX
$83.1M
– –
-113,636
ARCT icon
208
Arcturus Therapeutics
ARCT
$191M
– –
0
IOVA icon
209
Iovance Biotherapeutics
IOVA
$1.74B
– –
0
MDGL icon
210
Madrigal Pharmaceuticals
MDGL
$10.9B
– –
0
NVO
211
Novo Nordisk
NVO
$192B
– –
0
PAX icon
212
Patria Investments
PAX
$1.78B
– –
-365,000
SNDK
213
Sandisk
SNDK
$262B
– –
-24,000
LHAI
214
Linkhome Holdings
LHAI
$12.9M
– –
-75,000
ARKG icon
215
ARK Genomic Revolution ETF
ARKG
$1.23B
– –
0
BBIO icon
216
BridgeBio Pharma
BBIO
$13.3B
– –
-2,000
BTCS icon
217
BTCS Inc
BTCS
$54.3M
– –
-161,992
COIN icon
218
Coinbase
COIN
$40.5B
– –
-15,700
CRGO icon
219
Freightos
CRGO
$88.9M
– –
-143,269
DTIL icon
220
Precision BioSciences
DTIL
$160M
– –
-97,085
GPMT
221
Granite Point Mortgage Trust
GPMT
$70M
– –
-183,150
HCC icon
222
Warrior Met Coal
HCC
$5.01B
– –
-10,000
HIMS icon
223
Hims & Hers Health
HIMS
$6.45B
– –
0
HRMY icon
224
Harmony Biosciences
HRMY
$2.04B
– –
-415,000
INSM icon
225
Insmed
INSM
$20.9B
– –
0
7 8
9
10 11